• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Professional Introduction to N-(4-Formylthiazol-2-yl)acetamide (CAS No. 16444-13-6)

N-(4-Formylthiazol-2-yl)acetamide, a compound with the chemical formula C?H?NO?S, is a significant molecule in the field of pharmaceutical chemistry and biochemistry. This compound is characterized by its thiazole core structure, which is a heterocyclic compound containing sulfur and nitrogen atoms in its ring. The presence of a formyl group at the 4-position and an acetamide moiety at the 2-position makes it a versatile intermediate for various synthetic applications, particularly in the development of bioactive molecules.

The CAS number 16444-13-6 uniquely identifies this compound and serves as a key reference in scientific literature and databases. Its molecular structure imparts unique chemical properties that make it valuable in medicinal chemistry. The formyl group (CHO) is highly reactive and can participate in condensation reactions, forming Schiff bases and other derivatives that are often explored for their biological activity. The acetamide group (NHCOCH?) contributes to the compound's solubility and reactivity, making it suitable for further functionalization.

Recent advancements in drug discovery have highlighted the importance of thiazole derivatives due to their broad spectrum of biological activities. Thiazole-based compounds have been reported to exhibit antimicrobial, anti-inflammatory, anticancer, and antiviral properties. Among these, N-(4-formylthiazol-2-yl)acetamide has garnered attention for its potential in modulating enzyme activity and inhibiting pathogenic processes. For instance, studies have shown that derivatives of this compound can interact with specific enzymes involved in metabolic pathways, offering insights into their therapeutic potential.

In the realm of medicinal chemistry, the synthesis of N-(4-formylthiazol-2-yl)acetamide involves multi-step organic reactions that require precise control over reaction conditions. The formyl group's reactivity allows for facile coupling with nucleophiles such as amines and hydrazines, leading to the formation of Schiff bases and other heterocyclic compounds. These derivatives are often investigated for their pharmacological effects. Additionally, the acetamide moiety can be further modified through hydrolysis or amidation reactions, expanding the structural diversity of potential drug candidates.

One of the most compelling aspects of N-(4-formylthiazol-2-yl)acetamide is its role as a precursor in the synthesis of more complex bioactive molecules. Researchers have leveraged its structural features to develop novel therapeutic agents targeting various diseases. For example, modifications at the 4-position formyl group have led to compounds with enhanced binding affinity to biological targets. Similarly, variations at the acetamide position have been explored to optimize solubility and bioavailability, crucial factors in drug development.

The compound's relevance extends beyond academic research; it has found applications in industrial settings where high-throughput screening is employed to identify lead compounds for drug development. Its well-documented chemical properties make it an attractive candidate for library screening programs aimed at discovering new drugs with therapeutic efficacy. Furthermore, computational modeling techniques have been used to predict the binding interactions between N-(4-formylthiazol-2-yl)acetamide and biological targets, providing valuable insights into its mechanism of action.

Recent studies have also explored the pharmacokinetic profile of N-(4-formylthiazol-2-yl)acetamide and its derivatives. These investigations aim to understand how the compound is absorbed, distributed, metabolized, and excreted by the body. Such knowledge is essential for optimizing dosages and minimizing potential side effects. Advanced analytical techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize metabolites and degradation products, contributing to a comprehensive understanding of the compound's behavior in vivo.

The future prospects of N-(4-formylthiazol-2-yl)acetamide are promising, with ongoing research focusing on expanding its applications in drug discovery and therapeutic development. Innovations in synthetic methodologies continue to emerge, enabling more efficient production processes and allowing for rapid exploration of structural variations. Collaborative efforts between academic institutions and pharmaceutical companies are fostering interdisciplinary approaches that combine computational chemistry with experimental validation.

In conclusion, N-(4-formylthiazol-2-yl)acetamide (CAS No. 16444-13-6) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features make it a valuable building block for synthesizing bioactive molecules with diverse therapeutic applications. As research progresses, this compound will continue to play a crucial role in advancing our understanding of disease mechanisms and developing novel treatments.

• 1217486-96-8(N-[4-(fluoromethyl)-2-thiazolyl]-Acetamide)
• 50602-38-5(2-(acetylamino)-1,3-thiazole-4-carboxylic acid)
• 50772-53-7(N-(Chloroacetyl)2-amino-4-methylthiazol)
• 126533-86-6(4-Thiazolecarboxaldehyde, 2-(ethylamino)-)
• 904626-41-1(Propanamide,N-(4-formyl-2-thiazolyl)-)
• 1007650-66-9(2-hydroxy-N-(4-methyl-2-thiazolyl)-Acetamide)
• 1365272-30-5(N-Methyl-2-(methylamino)-1,3-thiazole-4-carboxamide)
• 521956-44-5(2-(dimethylamino)thiazole-4-carbaldehyde)
• 31557-88-7(Acetamide, 2-cyano-N-(4-methyl-2-thiazolyl)-)
• 7336-51-8(N-(4-Methylthiazol-2-yl)acetamide)